KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Long-Term Investments (2016 - 2026)

AbbVie has reported Long-Term Investments over the past 14 years, most recently at $268.0 million for Q4 2025.

  • Quarterly Long-Term Investments fell 3.94% to $268.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $268.0 million through Dec 2025, down 3.94% year-over-year, with the annual reading at $268.0 million for FY2025, 3.94% down from the prior year.
  • Long-Term Investments was $268.0 million for Q4 2025 at AbbVie, down from $291.0 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $310.0 million in Q2 2025 and troughed at $235.0 million in Q3 2022.
  • The 5-year median for Long-Term Investments is $273.5 million (2021), against an average of $275.2 million.
  • Year-over-year, Long-Term Investments surged 291.03% in 2021 and then dropped 14.75% in 2022.
  • A 5-year view of Long-Term Investments shows it stood at $277.0 million in 2021, then dropped by 13.0% to $241.0 million in 2022, then rose by 26.14% to $304.0 million in 2023, then decreased by 8.22% to $279.0 million in 2024, then dropped by 3.94% to $268.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Long-Term Investments are $268.0 million (Q4 2025), $291.0 million (Q3 2025), and $310.0 million (Q2 2025).